SOUTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire/ -- Sunesis Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that the company will be presenting at the following upcoming conferences during the month of December:
Piper Jaffray 20th Annual Health Care Conference
The New York Palace Hotel, New York
Tuesday, December 2, 2008
2:00 p.m. ET
RBC Capital Markets Healthcare Conference
The Westin Times Square, New York
Wednesday, December 10, 2008
1:30 p.m. ET
The live webcast of these presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
CONTACT: Eric Bjerkholt of Sunesis Pharmaceuticals, Inc., +1-650-266-3717
Web site: http://ir.sunesis.com/
http://www.sunesis.com/
